CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: While there is agreement on the surface phenotype defining CML LSCs (CD34+/CD38−/CD90+/CD26+), which might also include CD25+, IL-RAP1+ additional markers such as CD9, CD33, CD123 and CD56 were recently proposed [78,79,80].